Entries by The Snow Foundation

Dr. Fumihiko Urano | Washington University School of Medicine, USA | Prilenia Therapeutics

Dr. Fumihiko Urano Washington University School of Medicine, USA Dear Friends,   Thank you sincerely for your invaluable support of our collaborative study alongside Prilenia Therapeutics.  One promising candidate is the Sigma 1 receptor, and we have initiated a collaboration with Prilenia, a biotech company specializing in this field. Together, we are investigating the effects […]

AMYLYX PHARMACEUTICALS Helios Update

AMYLYX PHARMACEUTICALS Helios Update Earlier in February 2024, Amylyx Pharmaceuticals announced that enrollment was completed in the Phase 2 HELIOS clinical trial of AMX0035 (sodium phenylbutyrate and taurursodiol) for the treatment of Wolfram syndrome. HELIOS is a 48-week exploratory, open-label proof of biology study assessing the effect of AMX0035 on a number of measures, including pancreatic […]

2024 Support Drive, could you help?

2024 Support Drive, could you help? This year, we are funding four projects worth almost $400,000. Please donate today to support our community. Your gift will make a significant difference and help us achieve our goal. For More Information: https://thesnowfoundation.org/2024-support-drive-could-you-help/   https://thesnowfoundation.org/donate/  

Quest for a Cure across the globe

The Snow Foundation is grateful for the support it has received from people around the world. We would like to express our appreciation to Markus Klasenar for putting us on the map in Germany. Thanks to their fundraising efforts, we have raised 2,650 euros for our Quest for A Cure!

,

Groundbreaking research of Dr. Fumihiko Urano at Washington University School of Medicine, USA

Dr. Fumihiko Urano Washington University School of Medicine, USA Dear Friends,   I want to take a moment to express my deep gratitude for your unwavering belief in and support of our mission to find a cure for Wolfram syndrome. Your enduring encouragement has been a beacon of hope guiding us on this remarkable journey. […]